X
Xaira Therapeutics
A new era in medicine.
About Xaira Therapeutics
Xaira Therapeutics is an AI-focused biotechnology company that applies artificial intelligence across the drug discovery and development process. It develops generative AI models to design protein and antibody therapeutics and foundation models for biology and disease, combining machine learning research, data generation, and therapeutic product development.
Industry
Biotechnology (AI-driven drug discovery and development)
Headquarters
San Francisco Bay Area, California, USA (with additional locations in Seattle and London)
Company size
Approximately 182 employees (per third-party data aggregator, 2026)
Founded
Publicly launched in April 2024 (jointly incubated by ARCH Venture Partners and Foresite Labs)
What we do
Artificial intelligence for drug discoveryMachine learning researchGenerative AI models for protein and antibody designFoundation models for biology and diseaseBiological and clinical data generationTherapeutic product developmentLaboratory automation
Interested in Xaira Therapeutics?
Join our talent pool to be considered for future opportunities.